16_brunser.pdf
TRANSCRIPT
-
7/27/2019 16_brunser.pdf
1/30
Functional Fermented Milk Products
Brunser O. Gotteland M, Cruchet S.
Institute of Nutrition and Food Technology (INTA), Univ. of Chile, Santiago, Chile.
Avda. El Libano 5524, Macul, Santiago Chile.
Phone: 56-2-9781468; E-mail: [email protected]
http://00_60thnestle%20nutrition.pdf/ -
7/27/2019 16_brunser.pdf
2/30
The origin of fermented food is lost in the earliest stages of human history. Milk
and milk-derived products have constituted a significant part of the diet of all ethnic
groups at all ages, including a proportion of the food provided to infants. Because it was
difficult to preserve milk unspoiled, all cultures which have had access to the milk and
to a variety of other products such as cereals, fish, legumes, fruits etc., have resorted to
fermentation with dual aims of improving their taste, texture and digestibility and
preserving them for longer periods of time. As many populations consumed routinely
these kinds of foods, it is highly probable that children may have received them as part
of their diet, even during weaning. (1). In Europe and Western Hemisphere, in parts of
Africa and Asia, in Australia and parts of the South Pacific, fermented products derived
from cows milk became predominant, even though yogurt originated from Asia and
from species other than cows. Products like of kefir, koumiss and kuranga, prepared
from the milk of other species and which contained a wide range of microorganisms
including bacteria and yeasts, have been widely used in other parts of the world and are
also being investigated for their associated microbiota and the resulting compounds (2).
The fermented products obtained from American camelids (llamas, alpacas, vicunas,
guanacos) and from corn have not been studied in depth in this respect (3). While
preparation of fermented foodstuffs was initially an empirical process, interest was
progressively aroused about the microorganisms participating in this process, the
chemical reactions and the compounds resulting during fermentation, and the health
benefits derived from their consumption for variable periods of time, including for the
health of the gastrointestinal tract. The improvement of the techniques of food
preservation and the massive industrialization of food elaboration during the second part
of the last century resulted in a lesser utilization of fermentative procedures and in the
subsequent decrease of the intake of fermented foodstuffs. It is tempting to speculate
that this phenomenon may have resulted in changes of the resident microbiota of
individuals and that this may be related to the increased prevalence of allergies and
chronic inflammatory and autoimmune diseases which was simultaneously observed (4,
5).
Milk fermentation and metabolite production
Fermented products derived from milk result from fermentation of lactose by
different bacterial strains. According to the Codex Alimentarius of 1992 yogurt is
defined as a coagulated milk product resulting from fermentation of lactose by
2
-
7/27/2019 16_brunser.pdf
3/30
Lactobacillus bulgaricus and Streptococcus thermophilus. Other lactic acid bacteria
(LAB), such as Lactobacillus, Streptococcus and Bifidobacterium, can be added to
yogurt starters to produce fermented milks with specific textural, organoleptic or
functional (in the case of probiotic strains) characteristics. The elaboration of fermented
milks results from an intense fermentation process by the lactic acid bacteria, sometimes
in association with yeast, acetic bacteria or moulds. A permease transports lactose into
the bacterial cell where the disaccharide is hydrolysed by beta-galactosidase into
glucose and galactose; the latter is exported out of the cell while glucose is
phosphorylated and converted first to pyruvic acid by an aldolase and then to lactic acid
by the lactate dehydrogenase (6). There is a synergistic relation between S.
thermophilus and L. delbrueckii subsp. bulgaricus throughout the process of
fermentation: the former use for its growth the amino acids and peptides produced byL.
bulgaricus from milk proteins while the growth of L. bulgaricus is stimulated by
compounds produced by S. thermophilus such as carbon dioxide and short chain fatty
acids (7). Twenty to forty percent of the lactose present in milk is transformed into
lactic acid during the process of yogurt elaboration such that in the final product total
sugars represent 4.9-5.3 g/dL, with 3.8-4.0 g/dL of lactose, 1.0-1.2 g/dL of galactose
and traces of glucose. The lactic acid concentration in yogurt ranges between 0.7 and
1.2 g/dL and the pH between 3.9 and 4.2. The presence of bacterial lactase improves the
intestinal hydrolysis of the remnant lactose and makes it more digestible for
hypolactasic individuals. In addition, the orocecal transit time of fermented milk
products is slower compared with unfermented milk, allowing a more efficient action of
both the bacterial beta galactosidase and the residual human intestinal lactase. All these
processes may explain why yogurt intake improves lactose digestion and the digestive
symptomatology in hypolactasic children (8, 9).
During milk fermentation, some vitamins such as pantothenic acid and vitamin
B12 decrease while folic acid and niacin increase (10). The proteins in cows milk
represent a complex mixture of which about 80% are caseins and consist of four main
fractions (S1-, S2-, - and -caseins) which exist in an approximate proportion of
38:11:38:13 (11). One to two percent of the casein is hydrolysed by proteases of LAB,
releasing amino acid and peptides which are metabolized by the bacteria or accumulate
in the product. Milk triglycerides are not modified during the fermentation process due
to the absence of lipase in LAB. In addition, fermented milks also contain growth
3
-
7/27/2019 16_brunser.pdf
4/30
factors, hormones and immune-stimulating molecules such as peptidoglycans,
polysaccharides, teichoic acid (12). Some bioactive peptides deriving from milk protein
hydrolysis may also modulate the immune system, as well as inhibit pathogen growth,
or they exert anti-inflammatory activities (13, 14). Some peptides such as the casein-
macropeptide may also stimulate the growth of Bifidobacterium populations in the
colon (15).
Fermentation and production of hypotensive peptides
Fermentation of milk proteins by lactic-acid bacteria may result in the release of
tripeptides with blood pressure lowering activities. Two active peptides isoleucyl-
prolyl-proline (Ile-Pro-Pro) and Valyl-Prolyl-Proline (Val-Pro-Pro) have been isolated
consistently from casein digests by L. helveticusand have been shown to lower blood
pressure in spontaneously hypertensive rats and in humans with mild hypertension (16,
17). Although hypertension is considered a disease of mature and old age, the precursor
conditions leading to hypertension are often present at a very young age; furthermore,
hypertension secondary to a number of conditions (kidney, endocrine, neurological
diseases, etc) are frequent in childhood and for this reason it is important to consider all
preventive and therapeutic possibilities that may be useful at a young age, including
those resulting from the effect of bacterial fermentation upon food constituents (18-20).
In another study, middle-aged individuals with moderate hypertension (systolic
readings between 140 and 180 mm Hg and diastolic readings between 90 and 110 mm
Hg) received twice daily 150 ml of a milk fermented withL. helveticusLBK-16H for 10
weeks with 7,5 mg/100 g of Ile-Pro-Pro and 10 mg/100 g of Val-Pro-Pro.
Contemporarily, the control group received the same product as the experimental group
but without the two active peptides. During a four-week run in and during a follow up
period of equal duration patients and controls received either a product fermented by a
different probiotic or the control product. Blood pressure was monitored at the
beginning and at the end of the experimental period with an automatic, 24-hour pressure
recorder and, in addition every individual was subjected to nine blood pressure controls
in a medical office at regular predetermined intervals. There was a difference of 4,1
0,9 mm Hg in the systolic pressure and a 1,8 0,7 mm Hg between theL. helveticus
and the control groups, respectively (21). Reductions in blood pressure of this
4
-
7/27/2019 16_brunser.pdf
5/30
magnitude are considered of epidemiologic significance from the point of view of
public health (22). Although both Ile-Pro-Pro and Val-Pro-Pro have been reported to be
powerful inhibitors of the angiotensin-converting enzyme (ACE), no changes in its
activity was observed in any of the participants, suggesting that another mechanism,
independent of ACE may be operating.
In vivoand in vitroACE-inhibitory activity originating from the fractionation of
caseins has been detected in milk products using different bacterial strains in the
fermentation process (13, 23). These peptides are mainly of low molecular weight and
some of them only become apparent after the products of the bacterial activity upon the
casein fractions are further subjected to proteolysis by pepsin and trypsin in the
digestive tract (24). The functional importance of these peptides is that ACE is one ofthe main molecules that regulate blood pressure through its effects on the synthesis of
angiotensin II, a potent vasoconstrictor; at the same time, the process of angiotensin II
synthesis induces the degradation of bradykinin, a powerful vasodilator. The net result
is that the inhibition of ACE causes lowering of blood pressure (25). In a study carried
out in kefir prepared from goats milk, ACE-inhibitory peptides were detected mainly in
16 sequences of amino acids that showed anti-hypertensive activity, two of them being
especially potent. Digestion with gastric and pancreatic enzymes further hydrolyzed the
original peptides and some of the resulting products also exhibited vasomotor effects
(26).
Antimicrobial activity in fermented foodstuffs
A number of bioactive polypeptides have been identified as present in encrypted
form in milk proteins; these are released during the fermentation process and/or during
the digestion of these proteins by the gastric and pancreatic enzymes in the
gastrointestinal tract (13). The active peptides are stored in the proteins as propeptides
or as mature C- or N-terminal peptides that are released during proteolysis. Hill and
coworkers isolated in 1977 a number of antimicrobial peptides from casein (27). These
peptides are very potent and include families or single peptides called caseicidins,
isracidins, casocidin-I, kappacin and lactoferricin (28-30). In general, these peptides
exert lytic activity on bacteria by becoming inserted in the membrane and assembling to
form channels which disrupt it, allowing the income of water and the outward diffusionof electrolytes and small molecules. These antibacterial peptides have specificity for
5
-
7/27/2019 16_brunser.pdf
6/30
prokaryotic membranes. It has been shown recently that fermentation of sodium
caseinate by L. acidophilusDPC6026 produces three peptides that represent fragments
of isracidin, two of them with potent activity mostly against gram positive but also
against gram negative bacteria such as Streptococcus mutans, E. coli O157:H7 and
Enterobacter zakazakii. E. zakazakiihas been recognized as the etiological agent of a
form of meningitis in neonates and milk-based infant formula may have served as its
reservoir. The possibility of incorporating the peptides caseicins A or B derived from
cows milk protein may represent a protective mechanism against this agent and should
increase the interest in producing casein-based ingredients for protective purposes (31,
32).
Fermented foodstuffs in the prevention and treatment of acute diarrhea
The use of fermented milk products for their contribution to health has been
recorded since Biblical times; these were used in Ancient Egypt and by the Greeks and
Romans for their medicinal properties. Cheese has also been used for the same purposes
since remote times. The origin of yogurt is not known and was prepared from the milk
of buffaloes, cows, donkeys, sheep and goats. Acidified milks were considered as
particularly useful in the management of gastrointestinal diseases (33).
Marriott and Davidson postulated that acidification of milk would make it easier
to digest by the gastrointestinal tract of children and would prevent episodes of diarrhea
(34). In vitro studies that showed that acidified milk inhibits the growth of
enteropathogens seemed to confirm this observation (35). A number of early studies
also supported the idea that the oral administration of some bacteria had a positive effect
on the evolution of diarrhea associated with bacteria (36, 37) and it was suggested that
this was the result of the positive modulation of immunity by these agents (38).
Effects on bacterial diarrhea. The number of studies relating the administration
of fermented milk products to the evolution of diarrhea associated with
enteropathogenic bacteria is relatively limited. In a study carried out in the Karelian
Republic it was shown that administration of L. casei rhamnosusGG (LGG) was not
associated in infants and children with shortening of episodes of diarrhea associated
with bacterial enteropathogens (39). Clements and coworkers conducted studies to
evaluate in adult volunteers the capability of lactobacilli to prevent diarrhea associated
with enterotoxigenic E. coli with negative results, even when the LAB were
6
-
7/27/2019 16_brunser.pdf
7/30
administered in high doses and at frequent intervals (40, 41). This has been confirmed
by other studies which showed however that although the duration of the diarrhea is not
shortened, stool volumes may be significantly decreased (42, 43).
The use of fermented products not derived from milk for the management of
diarrhea has been evaluated mostly in Africa and in Asia, but again the number of
studies is also small. Yartey and coworkers compared the effectiveness of a fermented
maize gruel with the same unfermented preparation and with the WHO/UNICEF oral
rehydration solution in children with diarrhea. No differences in stool frequency and
duration of diarrhea were observed between treatments but the fermented product was
better accepted by the children than the unfermented control (44). This is in contrast
with the findings of another group in Tanzania who observed that children whoregularly consumed lactic-fermented cereal gruels had a 40 % lower frequency of
diarrhea during a nine month follow up compared to a control group who were not fed
these fermented products (45). Some fermented cereals have been shown to exert
antibacterial activity in vitro and to be effective in preventing diarrhea (46, 47). A recent
study in Northern Ghana evaluated in 190 children whose median age was 13 months
the effect of a spontaneously fermented millet product on diarrhea; the episodes of
diarrhea had lasted a median of 48 hours before the administration of the product had
been started; 24.4 % of the children were considered to be dehydrated and 90.2 % had
malaria parasites in their blood smears; the mean number of episodes of diarrhea in the
preceding 12 months was 2.7. The enteropathogens associated with the episodes of
diarrhea and the probiotic microorganisms in the product were not been characterized;
furthermore, the possible variation in the species of bacteria growing in the fermented
product or their counts were not assessed either (48). The product tested did not
improve the cure rate or the duration of the episodes of diarrhea compared to the heat-
inactivated control; furthermore, as a high proportion of the patients were receiving
concomitantly antibiotics and anti-malarial drugs it is not known to what extent this
affected the results.
In a study carried out in Santiago, Chile, 82 weaned infants less than 12 months
of age received a milk formula acidified by the addition of L. helveticus and S.
thermophilusfor a period of six months. A group of 104 infants who were comparable
from the anthropometric and socio-economic points of view and who received their
medical care in a nearby area served as controls and received a non fermented milk of
7
-
7/27/2019 16_brunser.pdf
8/30
comparable composition. Patients were contacted by nurses and pediatricians twice
weekly for detection of diarrhea. The acidified product exerted a clear preventive effect
on new episodes of diarrhea: the incidence of diarrhea, the number of days during which
children were affected and the duration of the episodes were significantly lower in the
infants receiving the acidified formula. No differences were observed in the species of
enteropathogens associated with the episodes of diarrhea; asymptomatic fecal shedding
of bacterial enteropathogens decreased throughout the observation period (49) (Table
1).
Effects on viral diarrhea. Different species and strains of lactic acid bacteria
have been evaluated for their capacity to modify the course of viral diarrhea and L.
rhamnosusGG (LGG) has been the most extensively tested, especially for its effects ondiarrhea associated with rotavirus infection in children. When administered in
association with fermented milk a significant shortening of the evolution of the disease
was observed, as the duration of the episodes was 1,4 0,8 days in those receiving the
fermented product with the probiotic versus 2,4 0,8 days in the controls (50) (Table
2). A similar effect was observed for L. reuteri when given in progressively higher
counts to infants and children with diarrhea due to rotavirus, pointing to a possible
dosage effect for these bacteria (51). A recent study in children attending day care
centers confirmed the positive effect of L. reuteri on acute diarrhea; the study also
included a group of children who received a formula with Bifidobacterium lactisBb12.
Both probiotics were associated with a decrease in the number of episodes of diarrhea
and these were shorter and with fewer days with fever; however, there was no effect on
respiratory morbidities (52). The comparison of the results obtained with both
probiotics favoredL. reuteri; this may indicate that there is specificity in the (positive)
effects of probiotic microorganisms with respect to the responses they elicit in the host.
This demonstration of specificity in the quality of the immune responses towards
enteropathogens is in agreement with earlier results obtained in Finland by Majamaa
and coworkers, who compared three groups of children who received either LGG, or L.
caseisubsp rhamnosus, or a combination of S. thermophilusandL. delbruekiiin a study
of their effects on acute diarrhea: LGG significantly shortened the duration of diarrhea.
In analyzing the immune responses elicited by these bacteria, the number of
immunoglobulin-secreting cells stimulated was comparable for the three groups, while
LGG administration was associated during convalescence with enhancement of IgA
8
-
7/27/2019 16_brunser.pdf
9/30
specific antibody-secreting cells to rotavirus and serum IgA antibodies (53). This
further supports the idea of the presence of specific capabilities in some of these
bacteria to stimulate local and systemic defensive mechanisms.
In addition to the specific mechanisms activated by lactic acid bacteria as part of
the defensive responses of the body vis a vis pathogenic microorganisms, other
processes probably involved in the defense against pathogens relate to the activation of
innate immunity and include aspects such as the modulation of the resident microbiota
of the gastrointestinal tract, the stimulation of mucus secretion, increased activity of
macrophages and neutrophils, changes in intestinal permeability, etc. (14, 54-58).
Fermented foods andHelicobacter pyloricolonization.
H. pylori is a highly prevalent pathogen which colonizes the human gastric
mucosa; it is considered as an aetiological factor for gastroduodenal ulcers and a risk
factor for gastric cancers. In developing countries, the infection by H. pylori begins
early in life and a high proportion of the paediatric population is colonized by this
pathogen. Most of them remain asymptomatic and may not be treated with antibiotics.
The antibiotic treatment has a high cost and is not 100% effective because of resistance
to these drugs and to problems with patient compliance due to gastrointestinal
intolerance. In addition children, when treated, are generally rapidly colonized again
with the pathogen. The consumption of fermented products with lactic acid bacteria,
including probiotics, have been proposed as alternative solutions to help in the
management ofH. pyloricolonization in at-risk populations. A multicenter, prospective,
randomized, double-blind, controlled study was carried out in 86 symptomatic H.
pylori-positive children to compare the standard eradication treatment (omeprazole,
amoxicillin, and clarithromycin) for 7 days with the same treatment supplemented with
a fermented milk containing L. caseiDN-114 001 for 14 days (59). Supplementation
with the fermented product significantly increased the eradication rate from 57.5% to
84.6% (p=0.0045). In another study, 65 children received the seven-day standard triple
therapy supplemented with 250 ml of a commercial yogurt containing B. animalisand
L. casei, or milk during 3 months. No differences in the rate of eradication were
observed between groups in this study (60). Cruchet et al used a commercial productcontaining L. johnsoniiLa1 or L. paracaseiST11 or their respective, heat-inactivated
9
-
7/27/2019 16_brunser.pdf
10/30
control provided daily during four weeks in 326 asymptomatic H. pylori-positive
children. No eradication was observed but a significant decrease in the values of the
13C-Urea Breath Test (13C-UBT) was detected in the children receiving live La1
whereas no differences were observed in the other groups. Interestingly, the magnitude
of the decrease in the UBT values induced by La1 intake correlated with the basal
values of UBT before treatment (61). In another study with a small number of
participants, a yogurt containing L. gasseri OLL 2716 (LG21) was administered daily
for 8 weeks to 12 children colonized withH. pylori. A 13C-UBT was performed and the
levels of serum pepsinogen I and II were measured after 4 and 10 weeks of yogurt
intake. No significant differences in the 13C-UBT values before and at 4 and 10 weeks
after ingestion were observed. The PG I/II ratio 4 weeks after the onset of ingestion was
significantly higher than before ingestion; as the PG I/II ratio is inversely correlated
with the level of inflammation in H. pylori-infected gastric mucosa, an increase in this
ratio may indicate a decrease of the H. pylori-associated gastric mucosal inflammation
in these children (62). These results, in addition to others obtained in adults, suggest that
fermented milk products and probiotics may be used to maintain low gastric densities of
H. pyloriin asymptomatic, colonized subjects and that when administered together with
antibiotics in symptomatic patients, these could be useful in increasing the eradication
rates and in decreasing the severity of gastric inflammation and of adverse effects.
Such protective effects may be due to the inhibition of H. pylorigrowth through
the release of bacteriocins or of organic acids by some strains of Lactobacillus or
Bifidobacterium, and to the decrease of the adhesion of the pathogen to gastric epithelial
cells (63). In addition, probiotics and fermented milk products may have a role in the
stabilization of the gastric barrier function, in the decrease of mucosal inflammation,
and the stimulation of the healing of the gastric mucosa; this is probably related to the
antioxidant and anti-inflammatory properties of these bacteria (64).
Fermented foods and intestinal motility
There are few studies in children that have focused on the relationship between
fermented foods and intestinal motility. Most of these have been carried out in adults
and, particularly, in the elderly. Although it is logical to suppose that the presence of
fermented foods and their associated microflora probably have beneficial effects on the
motor activities of the gut (65, 66), this has not been clearly demonstrated.
10
-
7/27/2019 16_brunser.pdf
11/30
Gluten fermentation in the management of celiac disease
Celiac patients should remain on a strict gluten-free diet for life; however, this is
a complicated proposition and many of them abandon the diet. Another problem with
maintaining a gluten-free diet is that wheat flour and gluten have useful properties that
are applicable to the industrial processing of foodstuffs and are widely employed to
thicken, increase the consistency, palatability and mouth of a great number of
preparations. The possibility of using the fermentative capabilities of bacteria to
hydrolyze gluten and gliadin to destroy their pathogenic capacity for celiac patients is
being actively explored in many laboratories. The rationale of this is that many bacteria,
including lactobacilli, have in their genetic program an extensive repertoire of proteases
that allow them to hydrolyze the peptide sequences in gluten, hordein and avenin
associated with the small intestinal lesions in celiac disease (67): the resulting products
would be harmless for the patients. Di Cagno and coworkers demonstrated that it was
possible to decrease considerably the concentration of gliadin using a mixture of L.
alimentarius15M, L. brevis14G, L. sanfrancisensis7A and L. hilgardii51B with the
purpose of fermenting wheat semolina used for the production of noodles, whose
resulting concentrations of gluten peptides were low; these culinary preparations hadsatisfactory sensory qualities when tasted by an expert panel (68).
The same group showed that the VSL#3 probiotic preparation has the capability
of decreasing in celiac patients the toxic capability of wheat flour after prolonged
fermentation, as evidenced by the absence of CD3+ lymphocytes in jejunal biopsies
incubated in vitro with the resulting gliadin digests. VSL#3 is a mixture of S.
thermophilus, L. plantarum, L. acidophilus, L. casei, L. delbrueckiispp. bulgaricus, B.
breve, B. longum andB. infantis(69).
The gluten-derived T-cell epitopes in gluten responsible for the pathogenesis of
the intestinal lesion in celiac disease are resistant to digestion by endoluminal proteases
because they are rich in proline. For this reason prolyl oligopeptidases appear as another
logical approach to the neutralization of the deletereous capacity of gliadin-derived
peptides. A prolyl endoprotease obtained from Aspergillus niger has recently been
shown to be stable at a wide range of pH and to resist digestion by pepsin. It degraded
all the synthetic T-cell stimulatory peptides tested derived from gliadin as well as the
intact protein and with greater speed than prolyl oligopetidase. Tests in patients are
11
-
7/27/2019 16_brunser.pdf
12/30
required to verify whether the in vivoresults are as promising as those observed in this
in vitrostudy (70).
The products of the fermentation of gliadin have been the object of a few
preliminary assays in celiac patients on a gluten-free diet but the results have not been
clear cut, due mostly to methodological problems (71).
Fermentation of carbohydrates: solving the problem of lactose maldigestion
and intolerance
Congenital deficiency of lactase activity is exceptional (72). Lactose
malabsorption develops sometimes after the intestinal mucosa has been damaged by
pathogens or, more frequently, due to the spontaneous disappearance of its activity in
adolescents and adults (73). Lactose maldigestion by individuals lacking the specific
hydrolytic enzyme, lactose-florizin hydrolase, a -galactosidase, or having low levels of
enzyme activity in the brush border of enterocytes of the upper part of the small
intestine may experience symptoms if the disaccharide load is high enough (lactose
intolerance). The symptoms associated with lactose intolerance are bloating, flatulence,
cramping pain and liquid stools sometimes expelled explosively (74). Affected
individuals learn instinctively how much lactose and lactose-containing products they
can tolerate without suffering unpleasant symptoms.
The best laboratory test for documentation of lactose malabsorption is the
measurement of hydrogen in breath after administration of a lactose load (75). The
relationship between the amount of lactose ingested and the magnitude of the symptoms
is not lineal as there is considerable variation in the responses of individuals to the same
dose of this disaccharide (76).
Because many of the bacteria associated with the production of fermented milk
products have lactase activity, intake of these products improves the symptoms of this
deficiency: yogurts and fermented milks improve the efficiency of lactose digestion.
The reasons for this are that the bacteria used to produce them survive their passage
through the acidic lumen of the stomach and their -galactosidase is released into the
lumen of the upper part of the small intestine by the bile salts, although some degree of
integrity of the bacterial bodies is required for proper lactase activity (77). The speciesmost frequently used for production of yogurts and fermented milk products in the
12
-
7/27/2019 16_brunser.pdf
13/30
Western countries, L. acidophilus, L. delbrueckiissp bulgaricus, S. thermophilus, etc.,
have high levels of lactase activity (7). By comparison some probiotics added to these
preparations have rather low lactase activity and they do not add importantly to the
lactase activity in the duodenum but may release it in the colon, where there is no
undigested lactose (74). Furthermore, the -galactosidase of many of these non
probiotic and probiotic species may have different pH optimums which differ from that
required for optimal digestion in the environment of the lumen of the gastrointestinal
tract.
Fermented milk products represent a useful, economic adjuvant for management
of lactose intolerance. One question repeatedly asked when feeding yogurt and
fermented products to infants and small children is whether the D(-)lactate synthesizedby the acidifying microorganisms may cause acidosis as the human body lacks the
enzyme required for its metabolism. Studies carried out in Santiago in six-month old
infants demonstrated that this is not the case (78), a finding that was corroborated
recently by Connolly and coworkers (79).
Probiotics and fermented foods for control of inflammatory bowel disease
In recent years it has been postulated that the two most frequent inflammatory
diseases of the gastrointestinal tract, ulcerative colitis and Crohndisease, are somehow
associated to alterations in the resident microbiota of the gastrointestinal tract and in the
responses this elicits in the local and systemic mechanisms of immunity. As a logical
result of this hypothesis, considerable interest was awakened on the effects of probiotics
and fermented foods on the severity, remission and relapse-free interval in these
diseases. In a preliminary study in four male patients with Crohns disease whose main
age was 14,5 years (range 10-18 years), Guandalini observed that it became possible to
taper corticosteroids in three of them because of clinical improvement in their
symptoms (80). A randomized, controlled study published contemporarily contradicted
the previous results because it did not reveal any improvements on clinical or
endoscopic recurrences or in the severity of the lesions (81). Other studies have tended
to confirm in general these latter results, including those of a multicenter evaluation in
which a large number of children were carefully followed while they received LGG in
addition to their standard maintenance therapy (low dose corticosteroids on alternate
13
-
7/27/2019 16_brunser.pdf
14/30
days, 6-mercaptopurin, aminosalicylates or azathioprine) (82-84). Whether other lactic
acid bacteria or probiotics may exert beneficial effects remains largely unanswered.
Fermented milk in the management of allergy
Atopic diseases such as eczema, allergic rhinitis and asthma are chronic allergic
disorders whose prevalence has increased five times during the past 20 years in the
developed countries (85). There is growing evidence suggesting an inverse association
between infections early in life and atopy, according to the hygiene hypothesis (86). The
higher frequency of (food) allergies is probably related to the industrial processing of
food, to changes in food consumption pattern and to alterations of the intestinal
microbiota. It is estimated that food allergies affect 3.5 % of adults and 8 to 10 % of
children; the allergens most frequently involved are egg, peanuts, milk, fish, nuts,
shellfish, wheat, kiwi and mustard.
Various studies have shown a relation between allergic conditions and the
composition of the gut microbiota. The levels of bifidobacteria in stools from allergic
infants, particularly those with atopic eczema, are significantly lower than those in
healthy subjects (87-89). Some other bacterial populations such as Clostridium,
Bacteroides and Staphylococcusmay also be altered and their concentrations may, in
some case, correlate with the serum concentrations of IgE. The distribution of
Bifidobacteriumspecies in the colon of allergic infants is characterized by higher levels
of B. adolescentis and B. longum and lower levels of B. bifidum, while the opposite
situation has been observed in healthy infants (90). This may predispose to the future
development of allergies as the former species are considered to be more characteristic
of the adult-type microbiota and associated with higher levels of the pro-inflammatory
cytokines TNF-and IL-12 by the macrophage-like cell line J774.1 in vitro (91). The
gut microbiota participates in the establishment of immune oral tolerance by reorienting
the Th2 responder phenotype of newborns towards the Th-1 cell-mediated immune
response and through the stimulation of TGF- and IgA secretion. In addition, the
microbiota is also involved in the regulation of the gut mucosal barrier, which blocks
the transfer of antigens across the mucosa; these antigens originate from the
environment, including foods, and are capable of initiating immune responses which are
altered in children with atopic eczema (92).
14
-
7/27/2019 16_brunser.pdf
15/30
Based on these findings, it has been proposed that intake of fermented food
products containing LAB could be used to modulate the homeostasis of the gut
microbiota and thus decrease symptomatology in infants at risk for allergy (93). About
13 clinical trials have been carried out to evaluate whether probiotic intake may
alleviate symptoms in infants with atopic eczema. They are randomized, double-blind
and placebo-controlled, and carried out in Finland by the same group of investigators
using mostly LGG and sometimes BifidobacteriumBb12. LGG consumption decreases
SCORAD as well as the fecal -1 antitrypsin and TNF-, plasmatic sCD4 and the
eosinophil protein X in urine (94, 95). Kalliomaki et al were the first to report a
decrease of atopic eczema in infants with family history of atopy when their mothers
were givenLactobacillusGG four weeks prepartum and during lactation (23% vs 46%,
in the probiotic and placebo groups, respectively; RR 0.51 [95% CI 0.32-0.84]) (96).
Interestingly, this protective effect of LGG against atopic eczema was subsequently
shown to persist until 4 years of age (97). Administration of probiotics to mothers was
also associated with a significant increase in TGF-2 levels in milk (98). In another
study in 230 children with atopic dermatitis, the daily administration of LGG for 4
weeks induced a greater decrease of SCORAD than in the placebo group but only in the
subgroup of IgE-sensitized children (99). In contrast with these results, Brouwer et al.
did not observe any improvement in SCORAD neither in its inflammatory parameters
(eosinophil protein X in urine, blood eosinophils, fecal -1 antitrypsin) and cytokines
production (IL-4, IL-5 and IFN-) by peripheral blood mononuclear cells, in 50 infants
less than five months receiving a hydrolyzed whey-based formula alone or
supplemented with LGG or withL. rhamnosusfor three months (100).
Some other studies have used probiotic strains (L. paracasei 33) in children
with allergic rhinitis, observing an improvement of the quality of life of these children
compared with the placebo group (101).
Effect of fermented foodstuffs on blood lipids
One aspect of the functional capabilities of fermented foodstuffs and their
bacteria that has been explored with considerable interest relates to their effects on lipid
metabolism, especially the triglyceride and cholesterol blood levels. Mann et al. carried
out the first studies in the Massai of Kenya and reported that the intake of large volumes
(4-5 liters per day) of fermented milk was associated with a decrease of up to 18% in
15
-
7/27/2019 16_brunser.pdf
16/30
their blood cholesterol (102). However, this study had methodological problems derived
from the fact that the subjects were drinking large volumes of fermented milk daily and
that they gained weight (the energy intake was 5500 Kcal/day) despite an intensive
program of physical exercise. This study awoke considerable interest and was followed
by others in which it was shown that fermented milk products have cholesterol lowering
effects, especially on total and LDL levels and that some of the products tested even
induced modest increases of HDL cholesterol in healthy, and especially in moderately
hypercholesterolemic adults; these effects are not exclusive of one species or strain of
bacteria and have been also observed with soy-based products but not with kefir (103-
110). Each publication on these subjects proposes different mechanisms to explain the
changes observed: incorporation of cholesterol to the membranes of bacteria, synthesis
of conjugated linoleic acid, deconjugation of bile salts, etc. (111-113), a suggestion that
a number of factors, rather than a single one, interact to produce the final result. These
studies have all been conducted in adults of varying ages and little is known about the
possible responses in children and their repercussion on long-term follow-up with
products that have demonstrated positive effects at older ages. It is tempting to postulate
that the bacteria used in the preparation of fermented products which decrease
cholesterol levels may leave some imprint in the metabolism of younger subjects,
probably on the enzymes participating in its endogenous synthesis.
In summary, fermented foods have a long history as components of the diet of
all human groups; the recent application of modern research methodologies is
demonstrating that the bacteria and the products of the fermentation processes in which
they participate intervene in a variety of activities that are positive for health and
wellbeing in all age groups.
16
-
7/27/2019 16_brunser.pdf
17/30
REFERENCES
1. Gastineau CF, Darby WJ, Turner T.B. Fermented beverages in nutrition. 1979. New
York: Academic Press.
2. Keogh BP. (1976) Microorganisms in dairy products friends and foes. PAG Bull
6: 34-41.
3. Todhunter EN. A historical perspective on fermentation biochemistry and nutrition.
In: Gastineau CF, Darby WJ, Turner TB, eds. Fermented beverages in nutrition.
1979. New York: Academic Press; 83-98.
4. Bach JF. (2005) Infections and autoimmune diseases. Autoimmun 25 Suppl: 74-80.
5. Holgate ST. (2004) Lessons learnt from the epidemic of asthma. QJM 97: 247-57.
6. Marshall V, Cole WM. (1983) Threonine aldolase and alcohol dehydrogenase
activities in Lactobacillus bulgaricus and Lactobacillus acidophilus and their
contribution to flavour production in fermented milk. J Dairy Res 50: 375-379.
7. Torriani S, Vescovo M, Dicks LMT. (1997) Streptococcus thermophilus and
Lactobacillus delbrueckii subsp. bulgaricus: a review. Ann Microbiol Enzimol
47:29-52.
8. Kolars JC, Levitt MD, Aouji M, Savaiano DA. (1984) Yogurt, an autodigesting
source of lactose. N Engl J Med 310: 1-3.
9. Shermak MA, Saavedra JM, Jackson TL, et al. (1995) Effect of yogurt on
symptoms and kinetics of hydrogen production in lactose-malabsorbing children.
Am J Clin Nutr 62:1003-06.
10. Reddy KP, Shahani KM, Kulkami SM. (1976) B-complex vitamins in cultured and
acidified yogurt. J Dairy Sci 59: 191-95.
11. Kunz C, Lnnerdal B. (1990) Human milk proteins: analysis of casein and casein
subunits by anion-exchange chromatography, gel electrophoresis, and specific
staining methods. Am J Clin Nutr 51: 37-46.
12. Meydani SN, Ha Woel-Kyu. (2000) Immunologic effects of yogurt. Am J Clin Nutr
71:861-72.
13. Meisel H. (2004). Multifunctional peptides encrypted in milk proteins. Biofactors
21: 55-61.
17
-
7/27/2019 16_brunser.pdf
18/30
14. Menard S, Candalh C, Bambou JC, Terpend K, Cerf-Bensussan N, Heyman M.
(2004) Lactic acid bacteria secrete metabolites retaining anti-inflammatory
properties after intestinal transport. Gut 53:821-28.
15. Etzel MR. (2004) Manufacture and use of dairy protein fractions. J Nutr 134: 996S-
1002S.
16. Sipola M, Fickenberg P, Korpela R, Vapaatalo H, Nurminen ML. (2002) Effect of
long term intake of milk products on blood pressure in hypertensive rats. J Dairy
Res 69: 103-11.
17. Seppo L, Kerojoki O, Suomalainen T, Korpela R. (2002) The effect of a
Lactobacillus helveticusLBK-16H fermented milk on hypertension a pilot study
in humans. Milk Sci Int 57: 124-27.
18. Sadowski RH, Falkner B. (1996). Hypertension in pediatric patients. Am J Kidney
Dis 27: 305-15.
19. Robinson RF, Nahata MC, Batisky DL, Mahan JD. (2005) Pharmacologic treatment
of chronic pediatric hypertension. Paediatr Drugs 7: 27-40.
20. Jones JE, Jose PA. (2005) Hypertension in young children and neonates. Curr
Hypertens Rep 7: 454-60.
21. Jauhiainen T, Vapaatalo H, Poussa T, Kyrnpalo S, Rasmussen M, Korpela R.
(2005) Lactobacillus helveticus fermented milk lowers blood pressure in
hypertensive subjects in 24-hour blood pressure measurement. Am J Hypertens 18:
1600-05.
22. MacMahon S, Rodgers A, Neal B, Chalmers J. (1997) Blood pressure lowering for
the secondary prevention of myocardial infarction and stroke. Hypertension 29: 537-
38.
23. Gobbetti M, Ferranti P, Smacchi E, Goffredi F, Addeo F. (2000) Production of
angiotensin-I-converting-enzyme inhibitory peptides in fermented milks started by
Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp.
cremorisFT4. Appl. Environment Microbiol 66: 3898-904.
24. Rokka T, Sivoja J, Tuominen J, Korhonen H. (1997) Release of bioactive peptides
by enzymatic proteolysis of Lactobacillus GG fermented UHT milk.Milchwissenschaft 52: 675-78.
18
-
7/27/2019 16_brunser.pdf
19/30
25. Ondetti MA, Cushman DW. (1982) Enzymes of the renin-angiotensin system and
their inhibitors. Ann Rev Biochem 51: 283-308.
26. Quirs A, Hernndez-Ledesma B, Ramos M, Amigo L, Recio I. (2005).
Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine
kefir. J Dairy Sci 88: 3480-87.
27. Hill RD, Lahov E, Givol D. (1974) A rennin-sensitive bond in alpha-S1 -casein. J
Dairy Res 41: 147-53.
28. Lahov E, Edelsten D, Sode-Morgensen MT, Sofer. (1971) Properties of basic
glycopeptides released from cow milk protein by heat. Milchwissenschaft 26: 489-
95.
29. Malkoski M, Dashper SG, OBrien-Simpson NM, Talbo M, Macris M, Cross KJ.
(2001) Kappacin, a novel antibacterial peptide from bovine milk. Antimicrob
Agents Chemother 45: 2309-15.
30. Zucht HD, Raida M, Aderman K, Magert HJ, Forssmann WG. (1995) Casocidin-I: a
casein--S2-derived peptide exhibits antibacterial activity. FEBS Lett 372: 185-88.
31. Nazarowec-White M, Farber JM. (1997) Thermal resistance of Enterobacter
zakazakiiin reconstituted dried infant formula. Lett Appl Microbiol 24: 9-13.
32. Hayes M, Ross RP, Fitzgerald GF, Hill C, Stanton C. (2006) Casein-derived
antimicrobial peptides generated by Lactobacillus acidophilus DPC6026. Appl
Environment Microbiol 72: 2260-64.
33. Gyrgy P. Effects of carbohydrates on intestinal flora. In: Sipple HL, McNutt KW,
eds. In: Sugars in nutrition. New York: Academic Press. 1974; 215-16.
34. Marriott WMK, Davidson IT. (1923) Acidified whole milk as routine infant feed.JAMA 81: 2007-10.
35. Schmidt BJ, Piva S. (1978) Le lait acidifi et son influence sur le developpement ( in
vitro) de la flore bactrienne. Med Hyg 36: 3277-84.
36. Pene P, Linhard J, Berbou JC (1966) The colibacillus-lactobacillus combination in
the treatment of diarrhea in adults, children and infants. Sem Hop 42: 241-44.
37. Pearce JL, Hamilton JR. (1966) Controlled trial of orally administered lactobacilli in
acute infantile diarrhea. J Pediatr 84: 261-62.
19
-
7/27/2019 16_brunser.pdf
20/30
38. Perdign G, Nader de Macias ME, Alvarez S, Medici M, Oliver G, Pesce de Ruiz
Holgado A.(1986) [Immunopotentiating activity of lactic bacteria administered by
oral route. Favorable effect in infantile diarrheas]. Medicina (B Aires) 46: 751-4.
39. Shornikova AV, Isolauri E, Burkanova L, Lukovnikova S, Vesikari T. (1997) A trial
in the Karelian Republic of oral rehydration and LactobacillusGG for treatment of
diarrhea. Acta Paediatr 86: 460.65.
40. Clements ML, Levine MM, Ristaino PA, Daya VE, Hughes TP.(1983) Exogenous
lactobacilli fed to man - their fate and ability to prevent diarrheal disease. Prog Food
Nutr Sci.7: 29-37.
41. Clements ML, Levine MM, Black RE, Robins-Browne RM, Cisneros LA, Drusano
GL, Lanata CF, Saah AJ. (1981) Lactobacillus prophylaxis for diarrhea due to
enterotoxigenicEscherichia coli. Antimicrob Agents Chemother.20: 104-8.
42. Costa-Ribeiro H, Ribeiro TC, Mattos AP, Valois SS, Neri DA, Almeida P,
Cerqueira CM, Ramos E, Young RJ, Vanderhoof JA. (2003) Limitations of
probiotic therapy in acute, severe dehydrating diarrhea. J Pediatr Gastroenterol Nutr
36: 112-15.
43. Salazar-Lindo E, Miranda-Langschwager P, Campos-Snchez M, Chea-Woo E,
Sack RB. (2004)Lactobacillus caseistrain GG in the treatment of infants with acute
watery diarrhea: a randomized, double blind, placebo controlled clinical trial. BMC
Pediatr 4: 18-27.
44. Yartey J, Nkrumah H, Hori H, Harrison K, Armar D. (1995) Clinical trial of
fermented maize-based oral rehydration solution in the management of acute
diarrhea in children. Ann Trop Paediatr 15: 61-68.
45. Lorri W, Svanberg U. (1994) Lower prevalence of diarrhoea in young children fed
lactic-acid fermented cereal gruels. Food Nutr Bull 15: 57-63.
46. Willumsen JF, Darling JC, Kitundu JA, Kingamkono RR, Msengi AE, Mduma B,
Sullivan KR, Tomkins AM. (1997) Dietary management of acute diarrhoea in
children: effect of fermented and amylase-digested weaning foods on intestinal
permeability. J Pediatr Gastroenterol Nutr 24: 235-41.
47. Saran S, Gopalan S, Krishna TP. (2002) Use of fermented foods to combat stunting
and failure to thrive. Nutrition 183: 93-96.
20
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=3114592&query_hl=2&itool=pubmed_DocSumhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=3114592&query_hl=2&itool=pubmed_DocSumhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=6657981&query_hl=11&itool=pubmed_DocSumhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=6792978&query_hl=11&itool=pubmed_DocSumhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=6792978&query_hl=11&itool=pubmed_DocSumhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=6792978&query_hl=11&itool=pubmed_DocSumhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=6792978&query_hl=11&itool=pubmed_DocSumhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=6657981&query_hl=11&itool=pubmed_DocSumhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=3114592&query_hl=2&itool=pubmed_DocSumhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=3114592&query_hl=2&itool=pubmed_DocSum -
7/27/2019 16_brunser.pdf
21/30
48. Lei T, Friis H, Fleischer Michaelsen K. (2006) Spontaneously fermented millet
product as a natural probiotic treatment for diarrhoea in young children: an
intervention study in Northern Ghana. Int J Food Microbiol 110: 246-53.
49. Brunser O, Araya M, Espinoza J, Guesry PR, Secretin MC, Pacheco I. (1989) Effect
of an acidified milk on diarrhoea and the carrier state in infants of low socio-
economic stratum. Acta Paediatr Scand 78: 259-64.
50. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. (1991) A human
Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from
acute diarrhea in children. Pediatrics 88: 90-97.
51. Shornikova AV, Casas IA, Mykkanen H, Salo E, Vesikari T. (1997) Bacteriotherapy
with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis 16: 1103-
07.
52. Weizman Z, Asli G, Alsheikh A. (2005) Effect of a probiotic infant formula on
infections in child care centers: comparison of two probiotic agents. Pediatrics 115;
5-9.
53. Majamaa H, Isolauri E, Saxelin M, Vesikari T. (1995) Lactic acid bacteria in the
treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 20: 333-38.
54. Dai D, Walker WA. (1999) Protective nutrients and bacterial colonization in the
immature gut. Adv. Pediatr 46: 353-82.
55. Donnet-Hughes A, Rochat F, Serrant P, Aeschlimann JM, Schiffrin EJ. (1999)
Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective
dose. J Dairy Sci 82: 863-9.
56. Heyman M, Terpend K, Mnard S. (2005) Effects of specific lactic acid bacteria on
intestinal permeability and the inflammatory condition. Acta Paediatr 94 (Suppl
449) 34-36.
57. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A. (1995)
Immunomodulation of human blood cells following the ingestion of lactic acid
bacteria. J Dairy Sci 78: 491-97.
58. Heyman M. (2002) Effect of lactic acid bacteria on diarrheal diseases. J Am Coll
Nutr 19: 137S-46S.
21
-
7/27/2019 16_brunser.pdf
22/30
59. Sykora J, Valeckova K, Amlerova J, Siala K, Dedek P, Watkins S, Varvarovska J,
Stozicky F, Pazdiora P, Schwarz J. (2005) Effects of a specially designed fermented
milk product containing probiotic Lactobacillus casei DN-114 001 and the
eradication ofH. pyloriin children: a prospective randomized double-blind study. J
Clin Gastroenterol 39: 692-8.
60. Goldman CG, Barrado DA, Balcarce N, Cueto Rua E, Oshiro M, Calcagno ML,
Janjetic M, Fuda J, Weill R, Salgueiro MJ, Valencia ME, Zubillaga MB, Boccio JR.
(2006) Effect of a probiotic food as an adjuvant to triple therapy for eradication of
Helicobacter pyloriinfection in children. Nutrition. In press [Epub ahead of print].
61. Cruchet S, Obregn MC, Salazar G, Diaz E, Gotteland M. (2003) Effect of the
ingestion of a dietary product containing Lactobacillus johnsonii La1 on
Helicobacter pyloricolonization in children. Nutrition 19: 716-21.
62. Shimizu T, Haruna H, Hisada K, Yamashiro Y. (2002) Effects of Lactobacillus
gasseri OLL 2716 (LG21) on Helicobacter pylori infection in children. J
Antimicrob Chemother 50: 617-8.
63. Gotteland M, Brunser O, Cruchet S. (2006) Systematic review: are probiotics useful
in controlling gastric colonization byHelicobacter pylori? Aliment Pharmacol Ther
23: 1077-86.
64. Gotteland M, Cruchet S, Verbeke S. (2001) Effect ofLactobacillusingestion on the
gastrointestinal mucosal barrier alterations induced by indomethacin in humans.
Aliment Pharmacol Ther 15: 11-7.
65. Salminen S, Salminen E. (1997) Lactulose, lactic acid bacteria, intestinal
microecology and mucosal protection. Scand J Gatroenterol Suppl 222: 45-48.
66. Adolfsson O, Meydani SN, Russell RM. (2004) Yogurt and gut function. Am J Clin
Nutr 80: 245-56.
67. Pridmore RD, Berger B, Desiere F, Vilanova D, Barretto C, Pittet AC, Zwahlen M-
C, Rouvet M, Altermann E, Barrangou R, Mollet B, Mercenier A, Klaenhammer T,
Arigoni F, Schell MA. (2004) The genome sequence of the probiotic intestinal
bacteriumLactobacilus johnsoniiNCC 533. PNAS 101: 2512-17.
22
-
7/27/2019 16_brunser.pdf
23/30
68. Di Cagno R, de Angelis M, Alfonsi G, de Vicenzi M, Silano M, Vincentini O,
Gobetti M. (2005) Pasta made from durum wheat semolina fermented with selected
lactobacilli as a tool for potential decrease of the gluten intolerance. J Agric Food
Chem 53: 4393-402.
69. De Angelis M, Rizzello CG, Fasano A, Clemente MG, De Simone C, Silano M, de
Vicenzi M, Losito I, Gobetti M. (2006) VSL#3 probiotic preparation has the
capacity to hydrolyze gliadin polypeptides responsible for celiac sprue. Biochim
Biophys Acta 1762: 80-93.
70. Stepniak D, Spaenij-Dekking L, Mitea C, Moester M, de Ru A, Baak-Pablo R, van
Veelen P, Edens L, Koning F. (2006) Highly efficient gluten degradation with a
newly identified prolyl endoprotease: implications for celiac disease. Am J Physiol
Gastrointest Liver Physiol 291: G621-9.
71. Cerf-Bensussan N, Matysiak-Budnik T, Cellier Ch, Heyman M. (2006) Oral
proteases: a new approach to managing celiac disease. Gut In Press.
72. Savilahti E, Launiala K, Kuitunen P. (1983) Congenital lactase deficiency. A
clinical study in 16 patients. Arch Dis Child 58: 246-52.
73. Scrimshaw NS, Murray EB. (1988) The acceptability of milk and milk products in
populations with a high prevalence of lactose intolerance. Am J Clin Nutr 48: 1083-
159.
74. de Vrese M, Stegelman A, Richter B, Fenselau S, Laue Ch, Schrezenmeir J. (2001)
Probiotics- compensation for lactase insufficiency. Am J Clin Nutr 73 (Suppl):
421S-29S.
75. Alliet Ph, Kretchmer N, Lebenthal E. Lactase deficiency, lactose malabsorption. and
lactose intolerance. In: Textbook of gastroenterology and nutrition in infancy. E.
Lebenthal, ed. 2nd edition. 1989. New York: Raven Press. 459-72.
76. Cavalli-Sforza LT, Strata A. (1986) Double-blind study on the tolerance of four
types of milk in lactose malabsorbers and absorbers. Hum Nutr Clin Nutr 40C: 19-
30.
77. Noh DO, Gilliano SE. (1994) Influence of bile on -galactosidase activity of
component species of yogurt starter cultures. J Dairy Sci 77: 3532-37.
23
-
7/27/2019 16_brunser.pdf
24/30
78. Brunser O, Haschke-Becher M, Gotteland M, Cruchet S, Pfeifer A, Magliola C,
Haschke F, Bachmann C. Urinary excretion of D(-) lactic acid after intake of a milk
formula that contains pre- or probiotics. (2000). Proc Latin Am Soc Pediatr Res.
Ushuaia. Argentina. Abstract No. 27.
79. Connolly E, Abrahamsson Th, Bjrkstn B. (2005) Safety of D(-) lactic acid
producing bacteria in the human infant. J Pediatr Gastroenterol Nutr 41: 489-92.
80. Guandalini S. (2002) Use ofLactobacillusGG in paediatric Crohns disease. Digest
Liver Dis 34 (Suppl.2): S63-65.
81. Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. (2002) Ineffectiveness of
probiotics in preventing recurrences after curative resection for Crohns disease: a
randomized controlled trial withLactobacillusGG. Gut 51: 405-09.
82. Schultz M, Tummer A, Herfarth HH, Sartor RB, Vanderhoof JA, Roth HO. (2004).
LactobacillusGG in inducing or mainataining remission of Crohns disease. BMC
Gastroenterol 15: 4-5.
83. Zocco MA, dal Verme LZ, Cremonini F, Piscaglia AC, Nista EC, Candelli M, Nori
M, Rigante D, Cazzato IA, Ojetti V, Armuzzi A, Gasbarrini A, Gasbarrini G.
(2006). Efficacy ofLactobacillusGG in maintaining remission of ulcerative colitis.
Aliment Pharmacol Ther 23: 1567-74.
84. Bousvaros A, Guandalini S, Baldassano RN, Botelho G, Evans J, Ferry GD, Goldin
B, Hartigau L, Kugathasau S, Levy J, Murray KF, Oliva-Hember M, Rosh JR, Tolic
V, Zholudev A, Vanderhoof JA, Hubbard PL. (2005). A randomized, double blind
trial ofLactobacillusGG versus placebo in addition to standard therapy in children
with Crohns disease. Inflamm Bowel Dis 11: 833-39.
85. Holgate ST. (1999) The epidemic of allergy and asthma. Nature 402 (6700 Suppl):
B2-4.
86. Bloomfield SF, Stanwell-Smith R, Crevel RW, Pickup J. (2006) Too clean, or not
too clean: the hygiene hypothesis and home hygiene. Clin Exp Allergy 36: 402-25.
87. Kirjavainen PV, Arvola T, Salminen SJ, Isolauri E. (2002) Aberrant composition of
gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut
51: 51-5.
24
-
7/27/2019 16_brunser.pdf
25/30
88. Watanabe S, Narisawa Y, Arase S, Okamatsu H, Ikenaga T, Tajiri Y, Kumemura M.
(2003) Differences in fecal microflora between patients with atopic dermatitis and
healthy control subjects. J Allergy Clin Immunol 111: 587-91.
89. Sepp E, Julge K, Mikelsaar M, Bjorksten B. (2005) Intestinal microbiota and
immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy 35
:1141-6.
90. He F, Ouwehand AC, Isolauri E, Hashimoto H, Benno Y, Salminen S. (2001)
Comparison of mucosal adhesion and species identification of bifidobacteria
isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 30: 43-7.
91. He F, Morita H, Ouwehand AC, Hosoda M, Hiramatsu M, Kurisaki J, Isolauri E,
Benno Y, Salminen S. (2002) Stimulation of the secretion of pro-inflammatory
cytokines byBifidobacteriumstrains. Microbiol Immunol 46: 781-5.
92. Majamaa H, Isolauri E. (1996) Evaluation of the gut mucosal barrier: evidence for
increased antigen transfer in children with atopic eczema. J Allergy Clin Immunol
97: 985-90.
93. Cross ML, Stevenson LM, Gill HS. (2001) Anti-allergy properties of fermented
foods: an important immunoregulatory mechanism of lactic acid bacteria? Int
Immunopharmacol 1: 891-901.
94. Majamaa H, Isolauri E. (1997) Probiotics: a novel approach in the management of
food allergy. J Allergy Clin Immunol 99: 179-85.
95. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. (2000) Probiotics in the
management of atopic eczema. Clin Exp Allergy 30: 1604-10.
96. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E.(2001)
Probiotics in primary prevention of atopic disease: a randomized placebo-controlled
trial. Lancet 357: 1076-79.
97. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. (2003) Probiotics
and prevention of atopic disease: 4-year follow-up of a randomized placebo-
controlled trial. Lancet 361: 1869-71.
98. Rautava S, Kalliomaki M, Isolauri E. (2002) Probiotics during pregnancy and
breast-feeding might confer immunomodulatory protection against atopic disease inthe infant. J Allergy Clin Immunol 109: 119-21.
25
-
7/27/2019 16_brunser.pdf
26/30
99. Viljanen M, Kuitunen M, Haahtela T, Juntunen-Backman K, Korpela R, Savilahti E.
(2005) Probiotic effects on faecal inflammatory markers and on faecal IgA in food
allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol 16:
65-71.
100. Brouwer ML, Wolt-Plompen SA, Dubois AE, van der Heide S, Jansen DF,
Hoijer MA, Kauffman HF, Duiverman EJ. (2006) No effects of probiotics on atopic
dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 36:
899-906.
101. Wang MF, Lin HC, Wang YY, Hsu CH. (2004) Treatment of perennial allergic
rhinitis with lactic acid bacteria. Pediatr Allergy Immunol 15: 152-58.
102. Mann GV, Spoerry A, Gray M, Jarashow D. (1972) Atherosclerosis in the
Masai. Am J Epidemiol 95: 26-37.
103. Agerbaeck M, Gerdes LU, Richelsen B. (1995) Hypocholestaerolemic effect of a
new fermented milk product in healthy middle-aged men. Eur J Clin Nutr 49: 346-
52.
104. Anderson JW, Gilliland SE. (1999) Effect of fermented milk (yogurt) containing
Lactobacillus acidophilusL1 on serum cholesterol in hypercholesterolemic humans.
J Am Coll Nutr 18: 43-50.
105. Drouault S, Corthier G. (2001) Effet des bactries lactiques ingeres avec les
laits ferments sur la sant. Vet Res 32: 101-17.
106. Xiao JZ, Kondo S, Takahashi N, Miyaji K, Oshida K, Harimatsu A, Iwatsuki K,
Kokubo S, Hosono A. (2003) Effects of milk products fermented by
Bifidobacterium longumon blood lipids in rats and healthy adult male volunteers. J
Dairy Sci 24: 52-61.
107. Lim H-J, Kim S_Y, Lee W-K. (2004). Isolation of cholesterol-lowering lactic
acid bacteria from human intestine for probiotic use. J Vet Sci 5: 391-95.
108. Heber D, Yip I, Ashley JM, Elashoff DA, Go VLW. (1999) Cholesterol-
lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J
Clin Nutr 69: 231-66.
26
-
7/27/2019 16_brunser.pdf
27/30
109. Rossi EA, Vendramini RC, Carlos IZ, de Oliveira MG, de Valdez GF. (2003)
Effect of a new fermented soy milk product on serum lipid levels in
normocholesterolemic adult men. Arch Latinoam Nutr 53: 47-51.
110. St-Onge M-P, Farnworth ER, Savard T, Chabot D, Mafu A, Jones PJH. (2002)
Kefir consumption does not alter plasma lipid levels or cholesterol fractional
synthesis rates relative to milk in hyperlipidemic men: a randomized controlled trial.
BMC Compl Altern Med 2:1.
111. Brashears MM, Gilliland SE, Buck LM. (1998) Bile salt deconjugation and
cholesterol removal from media byLactobacillus casei. J Dairy Sci 81: 2103-10.
112. Pereira DIA, Gibson GR. (2002) Cholesterol assimilation by lactic acid bacteria
and bifidobacteria isolated from the human gut. Appl Environment Microbiol 68:
4689-93.
113. Alonso L, Cuesta EP, Gilliland SE. (2003) Production of free conjugated linoleic
acid by Lactobacillus acidophilus and Lactobacillus casei of human intestinal
origin. J Dairy Sci 86: 1941-46.
27
-
7/27/2019 16_brunser.pdf
28/30
Table 1.- Incidence of episodes of acute diarrhea in relation to age in children who received an
acidified formula or a control non acidified formulaAcidified formula Control formula
Age(months)
Children/month
Episodes ofdiarrhea
Incidence Children/month
Episodes ofdiarrhea
Incidence
3-5 7 0 0 18 3 16,7
6-8 81 8 9,9 2=7,1235
p
-
7/27/2019 16_brunser.pdf
29/30
Table 2: Serum cholesterol changes in individuals randomly allocated to receive a
fermented milk containingLactobacillus acidophilusL1 (L1 FM) of human origin or
Lactobacillus acidophilusATCC 43211 (ATCC); placebo = fermented milk without
active bacteria. Values are expressed as mmol/L; means SEM.
Group No Baselineaverage
Week 2 Week 2 minusbaseline
% change
1st study
L1 FM 14 6,27 (0,19) 6,06 (0,17) - 0,21 (0,08) 3,2 (1,2)
ATCC FM 15 6,38 (0,23) 6,30 (0,23) - 0,08 (0,09) 1,2 (1,4)
2nd study
L1 FM 21 6,53 (0,17) 6,27 (0,18) - 0,26 (0,10) 3,8 (1,7)
Placebo 19 6,30 (0,14) 6,40 (0,13) - 0,10 (0,10) 1,9 (1,6)
Combined
L1 FM 35 6,42 (0,13) 6,18 (0,13) - 0,24 (0,07) - 3,6 (1,2)
P vs baseline 0,0015
P vs placebo 0,008
ANOVA 0,03
Modified from Anderson JW. (1999) J Am Coll Nutr 18: 43-50.
29
-
7/27/2019 16_brunser.pdf
30/30
Table 3.- Effect ofLactobacillus casei rhamnosusGG (LGG) on the recovery from acute
diarrhea in infants and preschool children (mean SD)
Group Duration of diarrhea, days
(1) Fermented milk with LGG 1,4 0,8
(2) Freeze-dried LGG 1,4 0,8
(3) Pasteurized yogurt 2,4 1,1
1 vs 3 and 2 vs 3:F=8,70; p < 0,001
The study was carried out in 71 well-nourished children 4 to 45 months of age; 82% ofcases were associated with rotavirus. The amounts of LGG provided were 10
10-11CFU in
125 g twice daily of fermented milk; freeze dried LGG: 1010-11 CFU once daily;pasteurized preparation 125 g twice daily.
Modified from Isolauri E et al. (1991). Pediatrics 88: 90-97.